Vilitra: Restore Confidence with Effective Erectile Function

Vilitra

Vilitra

Price from 61.92 $
Product dosage: 60mg
Package (num)Per pillPriceBuy
10$6.19$61.92 (0%)🛒 Add to cart
20$4.21$123.84 $84.28 (32%)🛒 Add to cart
30$3.55$185.76 $106.64 (43%)🛒 Add to cart
40$3.20$247.68 $128.14 (48%)🛒 Add to cart
60$2.88$371.52 $172.86 (53%)🛒 Add to cart
90$2.68$557.28 $240.80 (57%)🛒 Add to cart
120$2.56$743.04 $307.02 (59%)🛒 Add to cart
180
$2.45 Best per pill
$1114.56 $441.18 (60%)🛒 Add to cart
Synonyms

Similar products

Vilitra is a prescription medication containing Vardenafil, a potent PDE5 inhibitor specifically formulated to address erectile dysfunction (ED). It works by enhancing blood flow to the penile tissues upon sexual stimulation, facilitating the achievement and maintenance of an erection sufficient for satisfactory sexual activity. This treatment is intended for adult men and requires a proper medical diagnosis. Its efficacy is well-documented in clinical settings, offering a reliable pharmacological option for those seeking to improve their sexual health and intimate relationships.

Features

  • Active Pharmaceutical Ingredient: Vardenafil Hydrochloride
  • Available Strengths: 10 mg, 20 mg, 40 mg, and 60 mg film-coated tablets
  • Mechanism of Action: Selective inhibition of phosphodiesterase type 5 (PDE5)
  • Onset of Action: Typically within 25-60 minutes post-administration
  • Duration of Effect: Efficacy can last for up to 4-5 hours
  • Administration: Oral route, with or without food (though high-fat meals may delay absorption)
  • Manufacturer: Centurion Laboratories, complying with international GMP standards

Benefits

  • Facilitates reliable erectile response when sexually aroused, directly addressing the physiological mechanisms of ED.
  • Provides a substantial window of opportunity for spontaneity, reducing performance anxiety associated with timed interventions.
  • Contributes to improved self-esteem and relationship satisfaction by restoring sexual function.
  • Offers dosage flexibility, allowing for tailored therapeutic regimens under medical supervision.
  • Demonstrated high efficacy rates across various patient subgroups, including those with diabetes-related ED.
  • Supported by extensive clinical research confirming its safety and performance profile.

Common use

Vilitra (Vardenafil) is primarily indicated for the treatment of erectile dysfunction in adult males. It is used to enable individuals to achieve and sustain an erection sufficient for sexual intercourse. It is not indicated for use in women, children, or adolescents. Its use should be based on a confirmed diagnosis of ED by a healthcare professional, and it is not intended for recreational use or by individuals with normal erectile function.

Dosage and direction

The recommended starting dose for most patients is 10 mg, taken orally approximately 25 to 60 minutes prior to anticipated sexual activity. Based on efficacy and tolerability, the dose may be increased to 20 mg or decreased to 5 mg. The maximum recommended dosing frequency is once per day. Administration may occur with or without food; however, high-fat meals can delay absorption and time to onset. The tablet should be swallowed whole with a glass of water; it should not be split, crushed, or chewed.

Precautions

Prior to initiating treatment with Vilitra, a thorough medical assessment should be conducted to evaluate cardiovascular status, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical deformation of the penis, bleeding disorders, or active peptic ulceration. Patients with severe hepatic impairment should not exceed a 10 mg dose. Vilitra may cause dizziness and visual disturbances; caution is advised when driving or operating machinery. It offers no protection against sexually transmitted diseases.

Contraindications

Vilitra is contraindicated in patients with a known hypersensitivity to Vardenafil or any excipients in the formulation. Concomitant use with any form of organic nitrates or nitric oxide donors is strictly prohibited due to the risk of profound hypotension. It is also contraindicated in patients taking riociguat. Use is not recommended in men for whom sexual activity is inadvisable due to underlying cardiovascular pathology.

Possible side effect

Common adverse reactions include headache, flushing, nasal congestion, dyspepsia, and dizziness. Less frequently, patients may experience back pain, myalgia, nausea, or visual changes such as blurred vision and cyanopsia. Priapism, a prolonged and painful erection lasting more than 4 hours, is a rare but serious side effect requiring immediate medical attention to avoid permanent tissue damage. Sudden hearing loss or non-arteritic anterior ischemic optic neuropathy have been reported in temporal association with PDE5 inhibitor use.

Drug interaction

Concomitant administration with nitrates can result in severe hypotension. Concurrent use with alpha-blockers may potentiate the blood pressure-lowering effects. Vilitra is primarily metabolized by CYP3A4; therefore, potent inhibitors of this enzyme (e.g., ketoconazole, ritonavir, erythromycin) can significantly increase Vardenafil plasma levels and require dose adjustment. Inducers of CYP3A4 (e.g., rifampin) may decrease its efficacy. Grapefruit juice may increase absorption and should be avoided.

Missed dose

Vilitra is not intended for regular daily dosing but is taken on an as-needed basis prior to sexual activity. Therefore, the concept of a “missed dose” does not apply. It should only be taken when planned sexual activity is anticipated. Do not take an extra dose to make up for a missed opportunity.

Overdose

In cases of overdose, the primary expected manifestations would be an extension of its known vasodilatory effects, including severe hypotension, syncope, and prolonged erection. Standard supportive measures should be employed, including placing the patient in the supine position with the legs elevated to manage hypotension. Priapism requires immediate urological intervention. Hemodialysis is not expected to significantly accelerate clearance due to high protein binding and extensive tissue distribution.

Storage

Store at room temperature (15°C to 30°C) in a dry place, protected from light and moisture. Keep the blister strips in the original packaging until use. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.

Disclaimer

This information is intended for educational purposes only and does not constitute medical advice. Vilitra is a prescription medication and should only be used under the direct supervision and guidance of a qualified healthcare professional. Always consult your physician for a proper diagnosis and treatment plan tailored to your individual health status and needs. Do not initiate or alter any medication regimen without professional consultation.

Reviews

Clinical studies and post-marketing surveillance report high patient satisfaction rates, with many users noting significant improvement in erectile function and overall sexual experience. Efficacy is frequently described as reliable and predictable. The most commonly reported side effects are generally mild and transient. Many reviews highlight the importance of following the prescribed dosage and medical guidance to optimize results and minimize risks. Individual experiences may vary based on underlying health conditions, adherence to instructions, and psychological factors.